<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03716076</url>
  </required_header>
  <id_info>
    <org_study_id>H18-02232</org_study_id>
    <nct_id>NCT03716076</nct_id>
  </id_info>
  <brief_title>Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study</brief_title>
  <acronym>CaRDIO</acronym>
  <official_title>The Effect of Carbetocin Dose on Dispersion of Myocardial Repolarization in Healthy Parturients Scheduled for Elective Cesarean Delivery Under Spinal Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Relationship between carbetocin dose on transmural dispersion of repolarization (TDR).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Carbetocin is a uterotonic used to prevent postpartum hemorrhage. Although it has been proven&#xD;
      to be completely safe, little is known about its effects on the electrical activity of the&#xD;
      heart. The investigators aim to determine its effect on myocardial repolarization dynamics&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Actual">April 24, 2020</completion_date>
  <primary_completion_date type="Actual">June 15, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tp-e</measure>
    <time_frame>5 minutes post-carbetocin administration</time_frame>
    <description>Time interval between peak and end of T-wave (Tp-e)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arrhythmia</measure>
    <time_frame>perioperatively, typically ranging 30 minutes-1 hour</time_frame>
    <description>Occurrence of Atrial or Ventricular Arrhythmias</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QTc at 5 Min</measure>
    <time_frame>5 min post-carbetocin administration</time_frame>
    <description>Bazette corrected Q-T interval</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QTc 10 Min</measure>
    <time_frame>10 minutes post-carbetocin administration</time_frame>
    <description>Bazette corrected Q-T interval (QTc)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QTc 5 Min Spinal</measure>
    <time_frame>5 min post-administration of spinal anesthesia</time_frame>
    <description>Bazette corrected Q-T interval change after spinal anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tp-e 5 Min Post-spinal</measure>
    <time_frame>5 minutes after administration of spinal anesthesia</time_frame>
    <description>Time between peak and end of T-wave,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tp-e at 10 Min</measure>
    <time_frame>10 minutes post-carbetocin administration</time_frame>
    <description>Time between peak and end of T-wave</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Cardiac Arrythmias</condition>
  <arm_group>
    <arm_group_label>Participant receives 50 mcg of carbetocin post-delivery.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant receives 50 mcg of carbetocin post-delivery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Participant receives 100 mcg of carbetocin post-delivery.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant receives 100 mcg of carbetocin post-delivery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Carbetocin</intervention_name>
    <description>50 mcg or 100 mcg bolus of carbetocin</description>
    <arm_group_label>Participant receives 100 mcg of carbetocin post-delivery.</arm_group_label>
    <arm_group_label>Participant receives 50 mcg of carbetocin post-delivery.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant patients ≥ 36 weeks gestation, for elective Cesarean delivery under neuraxial&#xD;
             anesthesia&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) class 2&#xD;
&#xD;
          -  Patients ≥ 19 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Long QT syndrome&#xD;
&#xD;
          -  Cardiac disease or rhythm abnormalities&#xD;
&#xD;
          -  Family history of long QT syndrome or abnormal cardiac conduction&#xD;
&#xD;
          -  Currently taking medication that is known to prolong the QT interval&#xD;
&#xD;
          -  Women who are high risk for uterine atony as outlined in SOGC&#xD;
&#xD;
          -  Known allergic reaction or hypersensitivity to Carbetocin or any other oxytocin&#xD;
             homologue&#xD;
&#xD;
          -  Patients who are unable to give informed consent because of a language barrier as the&#xD;
             study team only speaks English and will be unable to complete consent process and&#xD;
             study procedure appropriately.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anton Chau, MD MMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BC Women's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3N1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 17, 2018</study_first_submitted>
  <study_first_submitted_qc>October 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2018</study_first_posted>
  <results_first_submitted>September 8, 2020</results_first_submitted>
  <results_first_submitted_qc>April 22, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 14, 2021</results_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Anthony Chau</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Carbetocin</keyword>
  <keyword>Myocardial repolarization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carbetocin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 26, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/76/NCT03716076/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 26, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/76/NCT03716076/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Participant Receives 50 mcg of Carbetocin Post-delivery.</title>
          <description>Participant receives 50 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
        </group>
        <group group_id="P2">
          <title>Participant Receives 100 mcg of Carbetocin Post-delivery.</title>
          <description>Participant receives 100 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Participant Receives 50 mcg of Carbetocin Post-delivery.</title>
          <description>Participant receives 50 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
        </group>
        <group group_id="B2">
          <title>Participant Receives 100 mcg of Carbetocin Post-delivery.</title>
          <description>Participant receives 100 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="19"/>
            <count group_id="B3" value="41"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.5" spread="4.3"/>
                    <measurement group_id="B2" value="35.7" spread="2.8"/>
                    <measurement group_id="B3" value="35" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean Arterial Pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89.7" spread="10.4"/>
                    <measurement group_id="B2" value="88.5" spread="8.3"/>
                    <measurement group_id="B3" value="89.2" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Heart Rate</title>
          <units>bpm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83.0" spread="8.6"/>
                    <measurement group_id="B2" value="81.8" spread="9.0"/>
                    <measurement group_id="B3" value="82.0" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gravida</title>
          <units>pregnancies</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2" lower_limit="2" upper_limit="3"/>
                    <measurement group_id="B2" value="2" lower_limit="2" upper_limit="3"/>
                    <measurement group_id="B3" value="2" lower_limit="2" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Parity of 0</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational Age</title>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.9" spread="0.8"/>
                    <measurement group_id="B2" value="39.2" spread="0.5"/>
                    <measurement group_id="B3" value="39.0" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Parity greater than 0</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline QTc</title>
          <description>Baseline Bazett-corrected Q-T interval</description>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="413.7" spread="11.0"/>
                    <measurement group_id="B2" value="409.0" spread="15.8"/>
                    <measurement group_id="B3" value="411.6" spread="13.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline Tp-e</title>
          <description>Time between peak and end of T-wave</description>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.5" spread="8.2"/>
                    <measurement group_id="B2" value="69.6" spread="5.7"/>
                    <measurement group_id="B3" value="68.5" spread="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>Kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74.9" spread="13.2"/>
                    <measurement group_id="B2" value="75.1" spread="10.7"/>
                    <measurement group_id="B3" value="75.0" spread="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Phenylephrine Dose</title>
          <units>micrograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1459.0" spread="426.1"/>
                    <measurement group_id="B2" value="1538.1" spread="479.2"/>
                    <measurement group_id="B3" value="1495.6" spread="500.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Tp-e</title>
        <description>Time interval between peak and end of T-wave (Tp-e)</description>
        <time_frame>5 minutes post-carbetocin administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Participant Receives 50 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 50 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
          <group group_id="O2">
            <title>Participant Receives 100 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 100 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
        </group_list>
        <measure>
          <title>Tp-e</title>
          <description>Time interval between peak and end of T-wave (Tp-e)</description>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.5" spread="7.7"/>
                    <measurement group_id="O2" value="74.7" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>mixed-effects linear regression</non_inferiority_desc>
            <other_analysis_desc>To compare time values to baseline, post-hoc Tukey's test was applied</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Arrhythmia</title>
        <description>Occurrence of Atrial or Ventricular Arrhythmias</description>
        <time_frame>perioperatively, typically ranging 30 minutes-1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Participant Receives 50 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 50 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
          <group group_id="O2">
            <title>Participant Receives 100 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 100 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
        </group_list>
        <measure>
          <title>Arrhythmia</title>
          <description>Occurrence of Atrial or Ventricular Arrhythmias</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>QTc at 5 Min</title>
        <description>Bazette corrected Q-T interval</description>
        <time_frame>5 min post-carbetocin administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Participant Receives 50 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 50 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
          <group group_id="O2">
            <title>Participant Receives 100 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 100 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
        </group_list>
        <measure>
          <title>QTc at 5 Min</title>
          <description>Bazette corrected Q-T interval</description>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="435.1" spread="18.3"/>
                    <measurement group_id="O2" value="434.2" spread="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>QTc 10 Min</title>
        <description>Bazette corrected Q-T interval (QTc)</description>
        <time_frame>10 minutes post-carbetocin administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Participant Receives 50 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 50 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
          <group group_id="O2">
            <title>Participant Receives 100 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 100 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
        </group_list>
        <measure>
          <title>QTc 10 Min</title>
          <description>Bazette corrected Q-T interval (QTc)</description>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="431.6" spread="18.2"/>
                    <measurement group_id="O2" value="431.9" spread="15.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>QTc 5 Min Spinal</title>
        <description>Bazette corrected Q-T interval change after spinal anesthesia</description>
        <time_frame>5 min post-administration of spinal anesthesia</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Participant Receives 50 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 50 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
          <group group_id="O2">
            <title>Participant Receives 100 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 100 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
        </group_list>
        <measure>
          <title>QTc 5 Min Spinal</title>
          <description>Bazette corrected Q-T interval change after spinal anesthesia</description>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="409.4" spread="19.2"/>
                    <measurement group_id="O2" value="413.6" spread="17.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tp-e 5 Min Post-spinal</title>
        <description>Time between peak and end of T-wave,</description>
        <time_frame>5 minutes after administration of spinal anesthesia</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Participant Receives 50 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 50 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
          <group group_id="O2">
            <title>Participant Receives 100 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 100 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
        </group_list>
        <measure>
          <title>Tp-e 5 Min Post-spinal</title>
          <description>Time between peak and end of T-wave,</description>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.5" spread="8.6"/>
                    <measurement group_id="O2" value="70.9" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tp-e at 10 Min</title>
        <description>Time between peak and end of T-wave</description>
        <time_frame>10 minutes post-carbetocin administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Participant Receives 50 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 50 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
          <group group_id="O2">
            <title>Participant Receives 100 mcg of Carbetocin Post-delivery.</title>
            <description>Participant receives 100 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
          </group>
        </group_list>
        <measure>
          <title>Tp-e at 10 Min</title>
          <description>Time between peak and end of T-wave</description>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.4" spread="8.2"/>
                    <measurement group_id="O2" value="71.8" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 days, which is the typical time spent in hospital for monitoring after cesarean sections</time_frame>
      <desc>Participants are screened for a history of intolerance to oxytocin, which puts them at low risk of intolerance/mortality or serious adverse reaction to carbetocin.&#xD;
Patients are monitored for minor adverse events, such as arrhythmia, which are potential side effects of carbetocin dosing.</desc>
      <group_list>
        <group group_id="E1">
          <title>Participant Receives 50 mcg of Carbetocin Post-delivery.</title>
          <description>Participant receives 50 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
        </group>
        <group group_id="E2">
          <title>Participant Receives 100 mcg of Carbetocin Post-delivery.</title>
          <description>Participant receives 100 mcg of carbetocin post-delivery.&#xD;
Carbetocin: 50 mcg or 100 mcg bolus of carbetocin</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No data exists that stratifies risk by measuring absolute Tp-e change We excluded patients with low repolarization reserves, or a resistance to oxytocin. We also excluded emergent C-sections, combined spinal/epidurals, and General Anesthesia</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Anthony Chau</name_or_title>
      <organization>BC Women's Hospital</organization>
      <phone>604-875-2158</phone>
      <email>anton.chau@ubc.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

